Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
The Journal of Urology|November 21, 2015
Pain and Urinary Symptoms Should Not be Combined into a Single Score: Psychometric Findings from the MAPP Research NetworkJames W Griffith, Alisa J Stephens-Shields, Xiaoling Hou, et al.Pain|November 5, 2024
Widespread pain phenotypes impact treatment efficacy results in randomized clinical trials for interstitial cystitis/bladder pain syndrome: a Multidisciplinary Approach to the Study of Chronic Pelvic Pain network studyJohn T Farrar, Kenneth T Locke, J Quentin Clemens, et al.Journal of the American Society of Nephrology : JASN|April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session DurationLaura M Dember, Eduardo Lacson, Steven M Brunelli, et al.Journal of the American Society of Nephrology : JASN|June 24, 2003
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and MethodsHarold I Feldman, Lawrence J Appel, Glenn M Chertow, et al.Neurourology and Urodynamics|June 25, 2020
The Multidisciplinary Approach to The Study of Chronic Pelvic Pain (MAPP) Research Network*: Design and implementation of the Symptom Patterns Study (SPS)J Quentin Clemens, Jason J Kutch, Emeran A Mayer, et al.The Journal of Urology|December 31, 2017
A Case-Crossover Study of Urological Chronic Pelvic Pain Syndrome Flare Triggers in the MAPP Research NetworkSiobhan Sutcliffe, Thomas Jemielita, H Henry Lai, et al.Kidney International Reports|February 14, 2022
One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) TrialMeghan Elizabeth Sise, David Seth Goldberg, Douglas Earl Schaubel, et al.Pain|July 11, 2017
Brain signature and functional impact of centralized pain: a multidisciplinary approach to the study of chronic pelvic pain (MAPP) network studyJason J Kutch, Eric Ichesco, Johnson P Hampson, et al.Journal of the American Society of Nephrology : JASN|August 27, 2020
Multicenter Study to Transplant Hepatitis C-Infected Kidneys (MYTHIC): An Open-Label Study of Combined Glecaprevir and Pibrentasvir to Treat Recipients of Transplanted Kidneys from Deceased Donors with Hepatitis C Virus InfectionMeghan E Sise, David S Goldberg, Jens J Kort, et al.BMC Urology|August 3, 2014
The MAPP research network: design, patient characterization and operationsJ Richard Landis, David A Williams, M Scott Lucia, et al.Pageof 11